NDC 60763-482 - GLYCOPYRROLATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60763-482
- Package NDCs from labels
- 60763-482-02
- Manufacturer
- Stason Pharmaceuticals | Stason Pharmaceuticals, Inc. | Contract Pharmacal Corp.
- Effective date
- 2021-12-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GLYCOPYRROLATE TABLETS USP 1 mg and 2 mg Rx only | Stason Pharmaceuticals | Stason Pharmaceuticals, Inc. | Contract Pharmacal Corp. | 2021-12-13 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 60763-482-02 | 2025-02-17 | C162847 | 48780-1 | f386c64a-19ba-0266-e053-dadaa90a7c1a | GLYCOPYRROLATE TABLETS USP 1 mg and 2 mg Rx only |
| 60763-482-02 | 2023-01-30 | C162847 | 48780-1 | f386c64a-19ba-0266-e053-dadaa90a7c1a | GLYCOPYRROLATE TABLETS USP 1 mg and 2 mg Rx only |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GLYCOPYRROLATE | GLYCOPYRROLATE | QUAGEN PHARMACEUTICALS LLC | 62e1ba35-bc84-4818-be54-8b534a1bf93c | 2026-09-10 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | f7187ddb-ea11-4aa8-8215-a5fcf0f1ca7c | 2026-09-09 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 4ecb3435-58e5-46cb-b8c2-85b5fd955f83 | 2026-09-09 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Par Health USA, LLC | 1f266d77-4f9e-44c9-a000-2f8fea3ac80b | 2026-07-09 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Amneal Pharmaceuticals LLC | bbab4cf1-0441-4fc4-9de9-e4117fa19faa | 2026-07-07 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Piramal Critical Care Inc | 83d70378-011b-4ce3-e053-2991aa0a22be | 2026-06-23 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Cardinal Health 107, LLC | 65688bed-0d70-4b51-8301-1948b1deade1 | 2026-06-02 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | REMEDYREPACK INC. | 220cd5f5-3d71-4fdb-9943-7468799c179f | 2026-06-02 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Golden State Medical Supply, Inc. | ec15e70c-8473-469a-9f07-ea668783fa07 | 2026-05-27 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Meitheal Pharmaceuticals Inc. | 02541cfd-b209-49b9-a73f-13ef18dce06d | 2026-05-20 | Warnings, Adverse reactions | V92SO9WP2I |
| Trimbow | BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE | Chiesi USA, Inc. | 4e13e70f-f550-4603-bbfb-346f80df3c4f | 2026-05-20 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Par Health USA, LLC | ff65c5d3-7ba9-4315-a884-199151eb45a5 | 2026-05-14 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Bryant Ranch Prepack | 098c7654-a352-47ee-bf23-6a81f8601266 | 2026-05-05 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Atlantic Biologicals Corp. | 50b493d7-8e3b-e459-e063-6394a90addbc | 2026-04-30 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Gland Pharma Limited | d670bd26-8a44-44be-90e1-107d4c380233 | 2026-04-28 | Warnings, Adverse reactions | V92SO9WP2I |
| glycopyrrolate | GLYCOPYRROLATE | Amneal Pharmaceuticals LLC | 741355f5-b695-41bb-a065-4abc687312b2 | 2026-04-28 | Warnings, Adverse reactions | V92SO9WP2I |
| BREZTRI | BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE | AstraZeneca Pharmaceuticals LP | 715433dc-cb2b-43ea-b6df-c5b4177adc6c | 2026-04-27 | Warnings, Adverse reactions | V92SO9WP2I |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| Glycopyrrolate | GLYCOPYRROLATE | Sagent Pharmaceuticals | 55930f87-8964-43b1-b790-c1e6dd2602d2 | 2026-04-20 | Warnings, Adverse reactions | V92SO9WP2I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.